Spontaneous regression of neuroblastoma.
Case of spontaneous regression of neuroblastoma continue to occur in the present multimodal therapy era at institutions where physicians are prepared to withhold treatment on certain patients with residual primary or metastatic disease. From a survey of the 22 member institutions of Children's Cancer Study Group, seven hospitals submitted data on 24 neuroblastoma patients whose disease underwent regression after minimal, unusual, or no treatment. An analysis of these patients and of 33 patients form two large series in the literature shows that the majority of patients are infants with Stage II or Stage IVS disease. The spontaneous regression usually consists of complete disappearance of the disease, but in some neuroblastomas, maturation to ganglioneuroma takes place. The various factors that may influence regression are discussed.
D000367:Age Factors; D000912:Antibodies, Neoplasm; D001667:Binding, Competitive; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007109:Immunity; D007223:Infant; D007231:Infant, Newborn; D008207:Lymphatic Metastasis; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009447:Neuroblastoma / Q000196:embryology / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D011247:Pregnancy
D000912:Antibodies, Neoplasm